Biotechnology Leaders Surveyed about Impact of Trump Presidency

| November 10, 2016

article image
The day following the election of Donald J. Trump as President, a survey of leaders in biotechnology in the United States, conducted by GENETIC ENGINEERING & BIOTECHNOLOGY NEWS (GEN), showed that Trump’s presidency will negatively impact NIH research funding as well as STEM education;  a plurality said it will also spark a “brain drain” as foreign-born researchers educated in American universities will be more likely to leave.

Spotlight

Bridges Home Healthcare

Bridges Home Healthcare is a full service home health care agency, offering both medical and non-medical home care throughout Southeastern Wisconsin. Our service area covers the counties of Dodge, Washington, Ozaukee, Milwaukee, Waukesha, Racine and Kenosha. At Bridges Home Healthcare, we strive to bridge the gap between personal health, financial resource, and health care. Our primary goal is to help create a community of caring, safety, and positive health outcomes while maintaining a holistic and cohesive continuum of care for the patient caregiver healthcare provider relationship.

OTHER ARTICLES

Top 10 biotech IPOs in 2019

Article | February 24, 2020

The big question at the start of 2019 was whether the IPO window would stay open for biotech companies, particularly those seeking to pull off ever-larger IPOs at increasingly earlier stages of development. The short answer is yes—kind of. Here’s the long answer: In the words of Renaissance Capital, the IPO market had “a mostly good year.” The total number of deals fell to 159 from 192 the year before, but technology and healthcare companies were standout performers. The latter—which include biotech, medtech and diagnostics companies—led the pack, making up 43% of all IPOs in 2019. By Renaissance’s count, seven companies went public at valuations exceeding $1 billion, up from five the year before

Read More

Cell Out? Lysate-Based Expression an Option for Personalized Meds

Article | February 18, 2020

Cell-free expression (CFE) is the practice of making a protein without using a living cell. In contrast with cell line-based methods, production is achieved using a fluid containing biological components extracted from a cell, i.e., a lysate. CFE offers potential advantages for biopharma according to Philip Probert, PhD, a senior scientist at the Centre for Process Innovation in the U.K.

Read More

Learning How FoxA2 Helps Turn Stem Cells into Organs

Article | March 18, 2020

Scientists at the Perelman School of Medicine at the University of Pennsylvania discovered early on in each cell, FoxA2 simultaneously binds to both the chromosomal proteins and the DNA, opening the flood gates for gene activation. The discovery, “Gene network transitions in embryos depend upon interactions between a pioneer transcription factor and core histones,” published in Nature Genetics, helps untangle mysteries of how embryonic stem cells develop into organs, according to the researchers. “Gene network transitions in embryos and other fate-changing contexts involve combinations of transcription factors. A subset of fate-changing transcription factors act as pioneers; they scan and target nucleosomal DNA and initiate cooperative events that can open the local chromatin. However, a gap has remained in understanding how molecular interactions with the nucleosome contribute to the chromatin-opening phenomenon,” write the investigators.

Read More

Biotech: Finding The DNA For Success

Article | April 3, 2020

The integration of artificial intelligence within life sciences is making drug discovery and development more innovative, less labor intensive and more cost-effective, says Deloitte’s annual global outlook. According to Deloitte’s 2020 Global Life Sciences Outlook, the biotech sector is at an inflection point. To prepare for the future and remain relevant in the ever-evolving business landscape, biopharma and medtech organizations will be looking for new ways to create value and new metrics to make sense of today’s wealth of data, the report overview says. As data-driven technologies provide biopharma and medtech organizations with treasure troves of information, and automation takes over some mundane tasks, new talent models are emerging based on purpose and meaning. The integration of artificial intelligence (AI) and machine learning approaches within life sciences is making drug discovery and development more innovative, time-effective and cost-effective, the Deloitte report states.

Read More

Spotlight

Bridges Home Healthcare

Bridges Home Healthcare is a full service home health care agency, offering both medical and non-medical home care throughout Southeastern Wisconsin. Our service area covers the counties of Dodge, Washington, Ozaukee, Milwaukee, Waukesha, Racine and Kenosha. At Bridges Home Healthcare, we strive to bridge the gap between personal health, financial resource, and health care. Our primary goal is to help create a community of caring, safety, and positive health outcomes while maintaining a holistic and cohesive continuum of care for the patient caregiver healthcare provider relationship.

Events